【摘要】：目的:分析并探討宮頸小細胞癌的臨床特征、治療方法和預(yù)后因素。方法:回顧性分析2007年7月1日至2014年6月30日新疆醫(yī)科大學(xué)附屬腫瘤醫(yī)院收治的21例宮頸小細胞癌患者的臨床資料,探究宮頸小細胞癌的臨床特點及預(yù)后因素。結(jié)果:按2009年國際婦產(chǎn)科聯(lián)盟分期,ⅠB~ⅡB期16例,ⅢB~Ⅳ期5例,到隨訪截止日期共有4例失訪,其余17例中7例發(fā)生遠處轉(zhuǎn)移,轉(zhuǎn)移部位為肝、肺、腦、骨骼,2例局部復(fù)發(fā);5例死亡病例生存時間分別為4、8、11、12、24個月,僅8例無瘤生存。17例患者中無瘤生存時間(PFS)為3~87個月,中位PFS為27個月,總生存時間(OS)為4~95個月,中位OS為27個月。結(jié)論:宮頸小細胞癌是一種罕見的婦科惡性腫瘤,鉑類化療是宮頸小細胞癌的一種行之有效的治療方式,推斷脈管浸潤、盆腔淋巴結(jié)轉(zhuǎn)移可能是宮頸小細胞癌的不良預(yù)后因素。
[Abstract]:Objective: to analyze and discuss the clinical features, treatment methods and prognostic factors of small cell carcinoma of the cervix. Methods: the clinical data of 21 patients with small cell carcinoma of the cervix were retrospectively analyzed from July 1, 2007 to June 30, 2014. The clinical features and prognostic factors of small cell carcinoma of the cervix were investigated. Results: according to the classification of International Federation of Obstetrics and Gynecology in 2009, there were 16 cases in stage 鈪，

本文編號：2313930